Forian (Forian) ROCE % : -7.07% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Forian ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Forian's annualized ROCE % for the quarter that ended in Mar. 2024 was -7.07%.

Forian ROCE % Historical Data

The historical data trend for Forian's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Forian ROCE % Chart

Forian Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-90.66

-85.49

-41.67

5.90

Forian Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial												-19.23	-7.33	47.17	-1.93	-7.07

Forian ROCE % Calculation

Forian's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	2.654	/	( ( (46.258 - 8.353)	+	(58.889 - 6.839) )	/ 2 )
	=	2.654	/	( (37.905	+	52.05)	/ 2 )
	=	2.654	/	44.9775
	=	5.90 %

Forian's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-3.644	/	( ( (58.889 - 6.839)	+	(57.495 - 6.469) )	/ 2 )
	=	-3.644	/	( ( 52.05	+	51.026 )	/ 2 )
	=	-3.644	/	51.538
	=	-7.07 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Forian (NAS:FORA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Forian ROCE % Related Terms

Thank you for viewing the detailed overview of Forian's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Forian (Forian) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Forian Inc (NAS:FORA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

41 University Drive, Suite 400, Newtown, PA, USA, 18940

Website

https://www.forian.com

Forian Inc provides a suite of SaaS solutions, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments, as well as cannabis dispensaries, manufacturers, cultivators, and regulators.

Executives

Martin J Wygod	director	P.O. BOX 676306, RANCHO SANTA FE CA 92067
Trotman Stanley S Jr	director
Max C Wygod	director, officer: Executive Chairman	41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Max Wygod Family Dynasty Trust	10 percent owner	41 UNIVERSITY DRIVE, SUITE 400, NEWTOWN PA 18940
Michael Vesey	officer: Chief Financial Officer	4041-T HADLEY ROAD, S. PLAINFIELD NJ 07080
Jennifer Hajj	director	41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Kristiina Md Vuori	director	C/O WEBMD HEALTH CORP., 111 EIGHTH AVENUE, NEW YORK NY 10011
Scott Matthew Ogur	director	C/O HELIX TCS, INC., 10200 E. GIRARD AVENUE, SUITE B420, DENVER CO 80231
Farren Clifford A Jr	officer: Chief Financial Officer	C/O SYNAVANT INC, 3445 PEACHTREE ROAD NE SUITE 1400, ATLANTA GA 30326
Adler Mark J Md	director
Ian Banwell	director	P.O. BOX 34004, CHARLOTTE NC 28234
Shahir Kassam-adams	director	41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Adam H Dublin	director, officer: Chief Strategy Officer	41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Daniel J Barton	director, officer: Chief Executive Officer	41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Alyssa F Varadhan	director	41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940